People News Roundup: Moby cancels book tour; 'Jon Snow' getting treatment

People News Roundup: Moby cancels book tour; 'Jon Snow' getting treatment
Image Credit: Twitter (@GameOfThrones)

Moby cancels book tour after furor over Natalie Portman claims

American musician Moby on Wednesday cancelled his book tour after mischaracterizing a past relationship with actress Natalie Portman in his new book. A message on his website said that Moby was cancelling "all upcoming public appearances for the foreseeable future." It was posted three days before he was due to start the UK leg of a tour to promote his memoir "Then It Fell Apart."

Stressed 'Game of Thrones' star Kit Harington getting treatment

"Game of Thrones" actor Kit Harington is undergoing treatment after the end of the HBO television series in which he starred as the heartthrob Jon Snow, his representative said on Tuesday. "Kit has decided to utilize this break in his schedule as an opportunity to spend some time at a wellness retreat to work on some personal issues," a representative for the British actor said in a statement.

Ashton Kutcher 'freaking out' after date found slain, Los Angeles court told

Actor Ashton Kutcher told a Los Angeles jury on Wednesday that he was "freaking out" after learning that a young woman was found dead in Hollywood the day after he called at her home for a date. The former "Two and a Half Men" star was testifying as a witness at the trial of a man dubbed the Hollywood Ripper who is charged with the murder of the young woman and two others.

'Jeopardy!' TV host Trebek reports 'mind-boggling' progress in cancer battle

Alex Trebek, the long-time host of television game show "Jeopardy!" and one of U.S. television's most recognizable personalities, said in an interview published on Wednesday that doctors have told him that his deadly pancreatic cancer is now "near remission." The 78-year-old Canadian-born host revealed in a video in March that he had been diagnosed with stage 4 pancreatic cancer, but vowed to beat the disease despite its low survival rate.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.